Progression patterns in patients with advanced hepatocellular carcinoma treated with local therapy, targeted drugs, and PD-1/PD-L1 inhibitors

Saved in:
Bibliographic Details
Main Authors: Yanan Zhao, Di Wu, Quanjun Yao, Hang Yuan, Hongtao Hu, Hailiang Li
Format: Article
Language:English
Published: Termedia Publishing House 2024-08-01
Series:Central European Journal of Immunology
Subjects:
Online Access:https://www.termedia.pl/Progression-patterns-in-patients-with-advanced-hepatocellular-carcinoma-treated-with-local-therapy-targeted-drugs-and-PD-1-PD-L1-inhibitors,10,54650,1,1.html
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1832584784029679616
author Yanan Zhao
Di Wu
Quanjun Yao
Hang Yuan
Hongtao Hu
Hailiang Li
author_facet Yanan Zhao
Di Wu
Quanjun Yao
Hang Yuan
Hongtao Hu
Hailiang Li
author_sort Yanan Zhao
collection DOAJ
format Article
id doaj-art-4995d03beafa4bfc979604183c54914b
institution Kabale University
issn 1426-3912
1644-4124
language English
publishDate 2024-08-01
publisher Termedia Publishing House
record_format Article
series Central European Journal of Immunology
spelling doaj-art-4995d03beafa4bfc979604183c54914b2025-01-27T11:12:34ZengTermedia Publishing HouseCentral European Journal of Immunology1426-39121644-41242024-08-0149214715410.5114/ceji.2024.14241854650Progression patterns in patients with advanced hepatocellular carcinoma treated with local therapy, targeted drugs, and PD-1/PD-L1 inhibitorsYanan ZhaoDi WuQuanjun YaoHang YuanHongtao HuHailiang Lihttps://www.termedia.pl/Progression-patterns-in-patients-with-advanced-hepatocellular-carcinoma-treated-with-local-therapy-targeted-drugs-and-PD-1-PD-L1-inhibitors,10,54650,1,1.htmlhepatocellular carcinoma disease progression local therapy targeted drug pd-1/pd-l1 inhibitor
spellingShingle Yanan Zhao
Di Wu
Quanjun Yao
Hang Yuan
Hongtao Hu
Hailiang Li
Progression patterns in patients with advanced hepatocellular carcinoma treated with local therapy, targeted drugs, and PD-1/PD-L1 inhibitors
Central European Journal of Immunology
hepatocellular carcinoma
disease progression
local therapy
targeted drug
pd-1/pd-l1 inhibitor
title Progression patterns in patients with advanced hepatocellular carcinoma treated with local therapy, targeted drugs, and PD-1/PD-L1 inhibitors
title_full Progression patterns in patients with advanced hepatocellular carcinoma treated with local therapy, targeted drugs, and PD-1/PD-L1 inhibitors
title_fullStr Progression patterns in patients with advanced hepatocellular carcinoma treated with local therapy, targeted drugs, and PD-1/PD-L1 inhibitors
title_full_unstemmed Progression patterns in patients with advanced hepatocellular carcinoma treated with local therapy, targeted drugs, and PD-1/PD-L1 inhibitors
title_short Progression patterns in patients with advanced hepatocellular carcinoma treated with local therapy, targeted drugs, and PD-1/PD-L1 inhibitors
title_sort progression patterns in patients with advanced hepatocellular carcinoma treated with local therapy targeted drugs and pd 1 pd l1 inhibitors
topic hepatocellular carcinoma
disease progression
local therapy
targeted drug
pd-1/pd-l1 inhibitor
url https://www.termedia.pl/Progression-patterns-in-patients-with-advanced-hepatocellular-carcinoma-treated-with-local-therapy-targeted-drugs-and-PD-1-PD-L1-inhibitors,10,54650,1,1.html
work_keys_str_mv AT yananzhao progressionpatternsinpatientswithadvancedhepatocellularcarcinomatreatedwithlocaltherapytargeteddrugsandpd1pdl1inhibitors
AT diwu progressionpatternsinpatientswithadvancedhepatocellularcarcinomatreatedwithlocaltherapytargeteddrugsandpd1pdl1inhibitors
AT quanjunyao progressionpatternsinpatientswithadvancedhepatocellularcarcinomatreatedwithlocaltherapytargeteddrugsandpd1pdl1inhibitors
AT hangyuan progressionpatternsinpatientswithadvancedhepatocellularcarcinomatreatedwithlocaltherapytargeteddrugsandpd1pdl1inhibitors
AT hongtaohu progressionpatternsinpatientswithadvancedhepatocellularcarcinomatreatedwithlocaltherapytargeteddrugsandpd1pdl1inhibitors
AT hailiangli progressionpatternsinpatientswithadvancedhepatocellularcarcinomatreatedwithlocaltherapytargeteddrugsandpd1pdl1inhibitors